CYTO

Altamira Therapeutics Ltd.

0.47 USD

Last updated Dec 1, 01:14 UTC

Yesterday HIGH

$0.72

Yesterday LOW

$0.2

52w HIGH

$6.23

52w LOW

$0.09

EPS

-1.41

PE

-0.33

Next Earnings

May 14, 2024

Overview News Government Trades

Altamira Therapeutics Ltd. stock is up 211.67% since 30 days ago. The next earnings date is May 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 9 December’s closed higher than November.

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Zug, Switzerland

Website

altamiratherapeutics.com

Benzinga Newsdesk

Fri Nov 10, 2023

Altamira Therapeutics Announces European Patent Office Decision To Grant For Patent Application Covering Intranasal Betahistine

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that it has received an "Intention to
Benzinga Insights

Mon Nov 6, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session
Lisa Levin

Fri Nov 3, 2023

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740.
Benzinga Insights

Fri Nov 3, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Lisa Levin

Fri Nov 3, 2023

Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Gainers Altamira Therapeutics Ltd (NASDAQ: CYTO) shares surged 54.1% to $0.25 in pre-market trading after gaining 5% on Thursday.
Benzinga Insights

Tue Oct 3, 2023

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 647 companies set new 52-week lows.
Lisa Levin

Fri Sep 15, 2023

Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Lisa Levin

Fri Sep 15, 2023

Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.
Benzinga Newsdesk

Thu Sep 14, 2023

Altamira Therapeutics Reports Additional Efficacy Outcomes From Bentrio Clinical Trial In Seasonal Allergic Rhinitis

Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy and tolerability of Bentrio® nasal spray in treatment of seasonal allergic rhinitis Study meets both primary
Benzinga Newsdesk

Tue Sep 12, 2023

Altamira Therapeutics H1 EPS $(1.41) Up From $(9.99) YoY, Sales $115.63K Down From $1.30M YoY

Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(1.41) per share. This is a 85.89 percent increase over losses of $(9.99) per share from the same period last year. The company reported $115.63 thousand